13F Insight
DOSSIER · 13F-HR · Q1 2026

HARBERT FUND ADVISORS, INC.

$3M in tracked AUM across 2 positions as of Q1 2026.

HF
CIK 0001616659 · last filed Mar 31, 2026
Total AUM
$3M
as of Q1 2026
Holdings
2
—
positions
Whale Score
57
57
tracked
Activity
—
no data
changes this Q
AI Analysis · Q1 2026
Portfolio Overview

Harbert Fund Advisors reports a materially smaller, highly concentrated long equity portfolio as of 2025-09-30: total 13F long value $12.11 million across 7 reported holdings, down 63.7% from $33.33 million at 2025-06-30. Turnover in the quarter was large — the filing lists 3 new positions, 16 sold-out positions, 2 reductions, and 2 unchanged positions — producing a net reduction in position count and a large net divestment of prior holdings. The current portfolio is concen...

A final important data point: 13F reporting covers only long U.S.-listed equities and convertible debt; this filing therefore may not reflect other asset classes (shorts, derivatives, private investments) or non-13F-eligible holdings.

Key Holdings
  • LQDA (Liquidia Corporation): $3.52M, 155,000 shares, 29.08% of the portfolio. Largest single position and a material stake relative to total assets.
  • PERCEPTIVE CAP SOLUTIONS COR: $3.18M, 300,000 shares, 26.27% of the portfolio. Second-largest holding; together with LQDA it represents over 55% of assets.
  • IDENTIV INC: $2.71M, 786,000 shares, 22.39% of the portfolio. Third-largest holding; the top three holdings collectively represent 77.74% of the reported portfolio value.
  • FENNEC PHARMACEUTICALS INC: $1.66M (13.75%).
  • OCULAR THERAPEUTIX (OCUL), NETSKOPE INC, 1RT ACQUISITION CORP comprise the remaining ~8.52% ($1.03M) of the portfolio.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
INVE
IDENTIV INC
$3M736K89.9%02
TACT
TRANSACT TECHNOLOGIES INC
$306K93K10.1%

Filing history

2026Q1Mar 31
$3M▼ 13.3%
2 positionsView →2025Q4Dec 31
$3M▼ 71.2%
2 positionsView →2025Q3Sep 30
$12M▼ 63.7%
7 positionsView →2025Q2Jun 30
$33M▼ 34.7%
20 positionsLocked2025Q1Mar 31
$51M▼ 73.5%
34 positionsLocked2024Q4Dec 31
$192M▲ 13.9%
95 positionsLocked2024Q3Sep 30
$169M▲ 20.1%
108 positionsLocked2024Q2Jun 30
$141M▼ 3.2%
100 positionsLocked2024Q1Mar 31
$145M▼ 0.4%
81 positionsLocked2023Q4Dec 31
$146M▲ 6.7%
70 positionsLocked2023Q3Sep 30
$137M▼ 23.3%
44 positionsLocked2023Q2Jun 30
$178M▲ 17.9%
45 positionsLocked
Showing 12 of 32